Translational Research in Malignancy Members
The Translational Research in Malignancy (TRIM) program is a highly interactive translational cancer research program. Its main objective is to conduct studies centered on molecular mechanisms of cancer progression and therapeutic resistance and to translate basic science and preclinical discoveries into early diagnosis, biomarkers, and cancer therapeutics.
Kalyan, Aparna
Associate Professor
Bio
My primary research focus is in early drug development in gastrointestinal malignancies. With a paradigm shift towards immunotherapy, my research is aimed at developing new and novel mechanisms of del... [more]
Karmali, Reem
Associate Professor
Bio
My research focuses on associations between disorders of energy metabolism and lymphoma pathogenesis. Specifically, my research has been driven by the hypothesis that cachexia is a metabolically and ... [more]
Kelleher, Neil
Professor
Bio
Natural Products Discovery and Biosynthesis, Top Down Mass Spectrometry, and Epiproteomics.
Khan, Irum
Associate Professor
Bio
Dr. Khan's research is focused on translation studies in myeloid malignancies. She focuses on identifying and validating therapeutic targets in myeloid leukemias using patient samples and animal ... [more]
Kumthekar, Priya U.
Associate Professor
Bio
My interests include treating primary brain tumors such as gliomas and meningiomas. I also have a specific interest in metastatic disease to the brain from systemic cancers such as melanoma, lung and ... [more]